Metraipolis › archive › dc_fa9d8e2f281b

Respiratory effects of nusinersen treatment in pediatric patients with spinal muscular atrophy types 2 and 3 — Europe PMC PMID:41114807

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41114807
DOI
10.1007/s00431-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-09T05:01:11.970Z
SHA-256 of the archived text
57cc62f10d1e98f07bcd1c39c24dbf7d5057d3e9e3dae8f99fe29f4e95872c9a
Stable URL of this page
https://metraipolis.com/documento/dc_fa9d8e2f281b

How to cite

Respiratory effects of nusinersen treatment in pediatric patients with spinal muscular atrophy types 2 and 3 — Europe PMC PMID:41114807 — Europe PMC (en), https://europepmc.org/article/MED/41114807 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa9d8e2f281b (Metraipolis archive dc_fa9d8e2f281b, sha256 57cc62f10d1e98f07bcd1c39c24dbf7d5057d3e9e3dae8f99fe29f4e95872c9a)
BibTeX
@misc{dcfa9d8e2f281b,
  title = {Respiratory effects of nusinersen treatment in pediatric patients with spinal muscular atrophy types 2 and 3 — Europe PMC PMID:41114807},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41114807},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa9d8e2f281b; sha256 57cc62f10d1e98f07bcd1c39c24dbf7d5057d3e9e3dae8f99fe29f4e95872c9a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41114807. Agents can read the archived copy with the MCP tool read_document.